Neuroscience
Congress Materials - International Society for Bipolar Disorders (ISBD 2025)
2025 International Society for Bipolar Disorders | Sep 17-19 | Chiba, Japan
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Lumateperone Treatment for Major Depressive Episodes with Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder: Post Hoc Analysis of Anhedonia
Suresh Durgam, Susan G. Kozauer, Willie R. Earley, Jason Huo, Ian D’Souza, Lakshmi N. Yatham
Response and Remission Outcomes of Lumateperone for Major Depressive Episodes with Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder
Suresh Durgam, Susan G. Kozauer, Willie R. Earley, Jason Huo, John B. Edwards, Roger S. McIntyre, Lakshmi N. Yatham
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.